Showing 3701-3710 of 9944 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0409_05-php/22843/JAK Inhibitors in Vitiligo Treatment
https://practicaldermatology.com/series/updates-vitiligo/jak-inhibitors-vitiligo-treatment/24559/Dr. Ted Lain, a dermatologist practicing in Austin, Texas, talks with Practical Dermatology about the latest developments and the promise of Janus kinase (JAK) inhibitors for the treatment of vitiligo. Dr. Lain covers the current impact of JAK inhibitors, their mechanism of action, how he's using thAn Inside Look at How Incyte is Addressing Unmet Needs of Patients with Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/an-inside-look-at-how-incyte-is-addressing-unmet-needs-of-patients-with-atopic-dermatitis/20156/Ahmad Naim, Vice President of US Medical Affairs at Incyte, discusses the challenges around atopic dermatitis (AD) management and how Incyte is utilizing its expertise in immunology to address unmet needs for patients.Opportunities and Barriers in Teledermatology
https://practicaldermatology.com/conferences/aad-2021/opportunities-and-barriers-in-teledermatology/19923/Dermatologists' participation in telemedicine has increased exponentially over the past year. But what does the future hold? What opportunities exist and what challenges remain? Jules Lipoff, MD weighs in.Where There's a WLL
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/where-theres-a-wll/19711/The Woodward Laser Eyelash Lift (WLL) uses an excision laser to provide a long-term lifting of the eyelashes. Creator Julie Woodward, MD describes the technique.DermWireTV Update
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-update/19125/Allergan is business as usual following a revised merger offer from Valeant. Get an update on the offer and Allergan's recent nominationfor the Prixe Galien USA.Journal Club: Treating Itch and Lessons from the IL-4 and IL-13 Blockade
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-treating-itch-and-lessons-from-the-il-4-and-il-13-blockade/27025/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, chats with dermatologist Matthew Zirwas, MD, about how evaluations of itch can lead to treatment for atopic dermatitis, and his Journal of Drugs in Dermatology article "Unexpected Clinical Lessons Learned From IL-4 and IL-13 Blockade."Cosmetic Options in Female Hair Loss
https://practicaldermatology.com/issues/august-2025/female-hair/36697/Female hair loss is a common issue addressed by dermatologists. It is a time-consuming problem to assess and treat. This article provides a methodical approach to female hair loss, including cosmetic options.How AI Tools Are Transforming the Work of Practicing Dermatologists
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/how-ai-tools-are-transforming-the-work-of-practicing-dermatologists/33163/Dermatologists wear many hats: clinician, researcher, educator, and often, practice manager.DermwireTV: Rinvoq Approved for Pediatric Psoriatic Arthritis; J&J Acquires Novel AD Candidate
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-rinvoq-approved-for-pediatric-psoriatic-arthritis/26269/In this week's DermwireTV, the FDA approves Rinvoq for pediatric psoriatic arthritis; Johnson & Johnson acquires an AD candidate for $1.25 billion; and the president of Acclaro Medical discusses the latest FDA clearance of its Ultraclear Laser.